Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of SABR-Comet

Category Primary study
JournalInternational Journal of Radiation Oncology Biology Physics
Year 2019
This article has no abstract
Epistemonikos ID: 37fcdab54d008d4f9e8d8d0cb18559c41ed6ede7
First added on: Feb 11, 2025